Advertisement

Comprehensive Data of P53 R282 Gene Mutation with Human Papillomaviruses (HPV)-Associated Oral Squamous Cell Carcinoma (OSCC)

  • Tipaya Ekalaksananan
  • Weerayut Wongjampa
  • Pensiri Phusingha
  • Jureeporn Chuerduangphui
  • Patravoot Vatanasapt
  • Supannee Promthet
  • Natcha Patarapadungkit
  • Chamsai PientongEmail author
Original Article

Abstract

Alterations of the P53 gene and human papillomavirus (HPV) infection are associated with development of oral squamous cell carcinoma (OSCC). We aimed to identify mutation of P53 exon 8 codon 282 in OSCC and correlate these with HPV infection as well as histopathological grade of OSCC. Samples of known HPV infection status were studied including oral lesion cells, formalin-fixed paraffin embedded (FFPE) tissues from OSCC and exfoliated oral cells of matched age-sex controls. P53 exon 8 mutation was detected using the polymerase chain reaction (PCR). Mutation of codon 282 was identified by allele-specific oligonucleotide typing (ASO) using EvaGreen real-time PCR. The PCR products were analyzed by gel electrophoresis and melting curve analysis. Mutation of P53 exon 8 was seen in 81.7% and 69.6% of FFPE OSCC tissues and oral lesion cells, respectively. This was significantly higher than in controls (16.7%). Frequency of mutation did not differ between HPV-positive samples (62.5% and 81.8% in oral lesion cells and FFPE tissue samples, respectively) and HPV-negative samples (73.3% and 81.5% in oral lesion cells and FFPE tissue samples, respectively). This finding is similar to P53 codon 282 mutation that was found only in FFPE tissues (35.0%) and oral lesion cells (32.6%) from both HPV-positive and negative OSCC. Interestingly, frequency of mutation was higher in well-differentiated OSCC with HPV-infection (28.1%) than without HPV (14.8%). This result demonstrated a mutation hot spot in P53 associated with oral carcinogenesis and might be useful to guide chemotherapeutic modality for HPV-associated OSCC in northeast Thailand.

Keywords

Human papillomavirus HPV P53 mutation P53 exon 8 codon 282 Oral squamous cell carcinoma OSCC Allele specific oligonucleotide ASO 

Notes

Acknowledgements

This work was supported by the Thailand Research Fund and Khon Kaen University through the Royal Golden Jubilee Ph.D. Program (grant number PHD/0296/2552, to W.W. and C.P.) and Invitation Research Grant, Faculty of Medicine, Khon Kaen University (grant number I56329). We would like to acknowledge Prof. David Blair, for editing the MS via Publication Clinic KKU, Thailand.

Compliance with Ethical Standards

Ethics Approval and Consent to Participate

All procedures performed in studies involving human participants were approved by the Khon Kaen University Ethics Committee for Human Research (No. HE561407 and No. HE581211), in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.

Conflict of Interest

The authors have no conflict of interest.

Supplementary material

12253_2019_673_MOESM1_ESM.doc (32 kb)
Supplementary Table 1 (DOC 32 kb)
12253_2019_673_MOESM2_ESM.doc (31 kb)
Supplementary Table 2 (DOC 31 kb)

References

  1. 1.
    Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80:827–841.  https://doi.org/10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P CrossRefGoogle Scholar
  2. 2.
    Tsantoulis P, Kastrinakis N, Tourvas A, Laskaris G, Gorgoulis V (2007) Advances in the biology of oral cancer. Oral Oncol 43:523–534.  https://doi.org/10.1016/j.oraloncology.2006.11.010 CrossRefGoogle Scholar
  3. 3.
    Krishna A, Singh S, Kumar V, Pal U (2015) Molecular concept in human oral cancer. Natl J Maxillofac Surg 6:9.  https://doi.org/10.4103/0975-5950.168235 CrossRefGoogle Scholar
  4. 4.
    Kashiwazaki H, Tonoki H, Tada M, Chiba I, Shindoh M, Totsuka Y, Iggo R, Moriuchi T (1997) High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay. Oncogene 15:2667.  https://doi.org/10.1038/sj.onc.1201438 CrossRefGoogle Scholar
  5. 5.
    Greenblatt M, Bennett WP, Hollstein M, Harris C (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855–4878Google Scholar
  6. 6.
    Fei P, El-Deiry WS (2003) P53 and radiation responses. Oncogene 22:5774.  https://doi.org/10.1038/sj.onc.1206677 CrossRefGoogle Scholar
  7. 7.
    Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, Olivier M (2007) Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 28:622–629.  https://doi.org/10.1002/humu.20495 CrossRefGoogle Scholar
  8. 8.
    Xu J, Wang J, Hu Y, Qian J, Xu B, Chen H, Zou W, Fang JY (2014) Unequal prognostic potentials of p53 gain-of-function mutations in human cancers associate with drug-metabolizing activity. Cell Death Dis 5:e1108.  https://doi.org/10.1038/cddis.2014.75 CrossRefGoogle Scholar
  9. 9.
    Suzuki H, Komiya A, Aida S, Ito H, Yatani R, Shimazaki J (1996) Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer. Prostate 28:318–324.  https://doi.org/10.1002/(SICI)1097-0045(199605)28:5<318::AID-PROS8>3.0.CO;2-7 CrossRefGoogle Scholar
  10. 10.
    He D, Zhang DK, Lam KY, Ma L, Ngan HYS, Liu SS, Tsao SW (1997) Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation. Int J Cancer 72:959–964.  https://doi.org/10.1002/(SICI)1097-0215(19970917)72:6<959::AID-IJC7>3.0.CO;2-O CrossRefGoogle Scholar
  11. 11.
    Busby-Earle R, Steel C, Williams A, Cohen B, Bird C (1994) p53 mutations in cervical carcinogenesis–low frequency and lack of correlation with human papillomavirus status. Br J Cancer 69:732.  https://doi.org/10.1038/bjc.1994.138 CrossRefGoogle Scholar
  12. 12.
    Oda D, Bigler L, Mao EJ, Disteche CM (1996) Chromosomal abnormalities in HPV-16-immortalized oral epithelial cells. Carcinogenesis 17:2003–2008.  https://doi.org/10.1093/carcin/17.9.2003 CrossRefGoogle Scholar
  13. 13.
    Lo K, Mok C, Chung G, Huang D, Wong F, Chan M, Lee J, Tsao S (1992) Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection. Anticancer Res 12:1989–1994Google Scholar
  14. 14.
    Phusingha P, Ekalaksananan T, Vatanasapt P, Loyha K, Promthet S, Kongyingyoes B, Patarapadungkit N, Chuerduangphui J, Pientong C (2017) Human papillomavirus (HPV) infection in a case-control study of oral squamous cell carcinoma and its increasing trend in northeastern Thailand. J Med Virol 89:1096–1101.  https://doi.org/10.1002/jmv.24744 CrossRefGoogle Scholar
  15. 15.
    Snijders AM, Schmidt BL, Fridlyand J, Dekker N, Pinkel D, Jordan RC, Albertson DG (2005) Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 24:4232.  https://doi.org/10.1038/sj.onc.1208601 CrossRefGoogle Scholar
  16. 16.
    Trivedy C, Warnakulasuriya K, Tavassoli M, Steingrimsdottir H, Penhallow J, Maher R, Johnson N (1998) p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SSCP. J Oral Pathol Med 27:72–77.  https://doi.org/10.1111/j.1600-0714.1998.tb02097.x CrossRefGoogle Scholar
  17. 17.
    Nylander K, Schildt E, Eriksson M, Magnusson A, Mehle C, Roos G (1996) A non-random deletion in the p53 gene in oral squamous cell carcinoma. Br J Cancer 73:1381.  https://doi.org/10.1038/bjc.1996.262 CrossRefGoogle Scholar
  18. 18.
    Ostwald C, Gogacz P, Hillmann T, Schweder J, Gundlach K, Kundt G, Barten M (2000) p53 mutational spectra are different between squamous-cell carcinomas of the lip and the oral cavity. Int J Cancer 88:82–86.  https://doi.org/10.1002/1097-0215(20001001)88:1<82::AID-IJC13>3.0.CO;2-N CrossRefGoogle Scholar
  19. 19.
    Chuerduangphui J, Pientong C, Patarapadungkit N, Chotiyano A, Vatanasapt P, Kongyingyoes B, Promthet S, Swangphon P, Bumrungthai S, Pimson C (2017) Amplification of EGFR and cyclin D1 genes associated with human papillomavirus infection in oral squamous cell carcinoma. Med Oncol 34:148.  https://doi.org/10.1007/s12032-017-1010-6 CrossRefGoogle Scholar
  20. 20.
    Lee YS, Bae SM, Kwak SY, Park DC, Kim YW, Hur SY, Park EK, Han BD, Lee YJ, Kim CK (2006) Cell cycle regulatory protein expression profiles by adenovirus p53 infection in human papilloma virus-associated cervical cancer cells. Cancer Res Treat 38:168.  https://doi.org/10.4143/crt.2006.38.3.168 CrossRefGoogle Scholar
  21. 21.
    Muller PA, Vousden KH (2014) Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer Cell 25:304–317.  https://doi.org/10.1016/j.ccr.2014.01.021 CrossRefGoogle Scholar
  22. 22.
    Javid J, Masroor M, Rashid Mir A, Ahamad I, Farooq S (2012) Clinical and prognostic significance of R282W p53 gene mutation in North India patients with non small cell lung Cancer. Transl Med 2:2161–1025.1000110.  https://doi.org/10.4172/2161-1025.1000110 CrossRefGoogle Scholar
  23. 23.
    Acharya S, Ekalaksananan T, Vatanasapt P, Loyha K, Phusingha P, Promthet S, Kongyingyoes B, Pientong C (2015) Association of Epstein-Barr virus infection with oral squamous cell carcinoma in a case–control study. J Oral Pathol Med 44:252–257CrossRefGoogle Scholar
  24. 24.
    Kang CJ, Lin CY, Wang HM, Fan KH, Ng SH, Lee LY, Chen IH, Huang SF, Liao CT, Yen TC (2011) The number of pathologically positive lymph nodes and pathological tumor depth predicts prognosis in patients with poorly differentiated squamous cell carcinoma of the oral cavity. Int J Radiat Oncol Biol Phys 81:e223–e230.  https://doi.org/10.1016/j.ijrobp.2011.03.060 CrossRefGoogle Scholar
  25. 25.
    Montoro JRMC, Hicz HA, Souza L, Livingstone D, Melo DH, Tiveron RC, Mamede RCM (2008) Prognostic factors in squamous cell carcinoma of the oral cavity. Rev Bras Otorrinolaringol 74:861–866.  https://doi.org/10.1590/S0034-72992008000600008 CrossRefGoogle Scholar
  26. 26.
    Mishra A, Bharti AC, Varghese P, Saluja D, Das BC (2006) Differential expression and activation of NF-κB family proteins during oral carcinogenesis: role of high risk human papillomavirus infection. Int J Cancer 119:2840–2850.  https://doi.org/10.1002/ijc.22262 CrossRefGoogle Scholar
  27. 27.
    Wong YK, Liu TY, Chang KW, Lin SC, Chao TW, Li PL, Chang CS (1998) p53 alterations in betel quid- and tobacco-associated oral squamous cell carcinomas from Taiwan. J Oral Pathol Med 27:243–248.  https://doi.org/10.1111/j.1600-0714.1998.tb01950.x CrossRefGoogle Scholar
  28. 28.
    Heaton CM, Durr ML, Tetsu O, Zante A, Wang SJ (2014) TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma. Laryngoscope 124.  https://doi.org/10.1002/lary.24595
  29. 29.
    Thongsuksai P, Boonyaphiphat P, Sriplung H, Sudhikaran W (2003) p53 mutations in betel-associated oral cancer from Thailand. Cancer Lett 201:1–7.  https://doi.org/10.1016/S0304-3835(03)00417-8 CrossRefGoogle Scholar
  30. 30.
    Zhang Y, Coillie S, Fang J, Xu J (2016) Gain of function of mutant p53: R282W on the peak? Oncogenesis 5:e196.  https://doi.org/10.1038/oncsis.2016.8 CrossRefGoogle Scholar
  31. 31.
    Hsieh LL, Wang PF, Chen I-H, Liao CT, Wang HM, Chen MC, Chang JTC, Cheng AJ (2001) Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese. Carcinogenesis 22:1497–1503.  https://doi.org/10.1093/carcin/22.9.1497 CrossRefGoogle Scholar
  32. 32.
    Sharan RN, Mehrotra R, Choudhury Y, Asotra K (2012) Association of betel nut with carcinogenesis: revisit with a clinical perspective. PLoS One 7:e42759CrossRefGoogle Scholar
  33. 33.
    Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P (2002) Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21:7435CrossRefGoogle Scholar
  34. 34.
    Scheidt JHG, Yurgel LS, Cherubini K, Figueiredo MAZ, Salum FG (2012) Characteristics of oral squamous cell carcinoma in users or non users of tobacco and alcohol. Revista Odonto Ciência 27:69–73CrossRefGoogle Scholar
  35. 35.
    Paquette RL, Lee YY, Wilczynski SP, Karmakar A, Kizaki M, Miller CW, Koeffler HP (1993) Mutations of p53 and human papillomavirus infection in cervical carcinoma. Cancer 72:1272–1280.  https://doi.org/10.1002/1097-0142(19930815)72:4<1272::AID-CNCR2820720420>3.0.CO;2-Q CrossRefGoogle Scholar
  36. 36.
    Dai M, Clifford GM, Le Calvez F, Castellsagué X, Snijders PJ, Pawlita M, Herrero R, Hainaut P, Franceschi S (2004) Human papillomavirus type 16 and TP53 mutation in oral cancer: matched analysis of the IARC multicenter study. Cancer Res 64:468–471.  https://doi.org/10.1158/0008-5472 CrossRefGoogle Scholar
  37. 37.
    Shima K, Kobayashi I, Saito I, Kiyoshima T, Matsuo K, Ozeki S, Ohishi M, Sakai H (2000) Incidence of human papillomavirus 16 and 18 infection and p53 mutation in patients with oral squamous cell carcinoma in Japan. Br J Oral Maxillofac Surg 38:445–450.  https://doi.org/10.1054/bjom.2000.0162 CrossRefGoogle Scholar
  38. 38.
    Singh RD, Patel KR, Patel PS (2016) p53 mutation spectrum and its role in prognosis of oral cancer patients: a study from Gujarat, West India. Mutat Res-Fund Mol M 783:15–26.  https://doi.org/10.1016/j.mrfmmm.2015.12.001 CrossRefGoogle Scholar
  39. 39.
    Schwartz SR, Yueh B, McDougall JK, Daling JR, Schwartz SM (2001) Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 125:1–9.  https://doi.org/10.1067/mhn.2001.116979 CrossRefGoogle Scholar
  40. 40.
    Chiba I, Shindoh M, Yasuda M, Yamazaki Y, Amemiya A, Sato Y, Fujinaga K, K-i N, Fukuda H (1996) Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity. Oncogene 12:1663–1668Google Scholar
  41. 41.
    Attner P, Du J, Näsman A, Hammarstedt L, Ramqvist T, Lindholm J, Marklund L, Dalianis T, Munck-Wikland E (2011) Human papillomavirus and survival in patients with base of tongue cancer. Int J Cancer 128:2892–2897.  https://doi.org/10.1002/ijc.25625 CrossRefGoogle Scholar
  42. 42.
    Klozar J, Kratochvil V, Salakova M, Smahelova J, Vesela E, Hamsikova E, Betka J, Tachezy R (2008) HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol 265:75–82.  https://doi.org/10.1002/ijc.25625 CrossRefGoogle Scholar
  43. 43.
    Brandwein M, Zeitlin J, Nuovo G, MacConnell P, Bodian C, Urken M, Biller H (1994) HPV detection using “hot start” polymerase chain reaction in patients with oral cancer: a clinicopathological study of 64 patients. Mod Pathol 7:720–727Google Scholar
  44. 44.
    Sisk EA, Soltys SG, Zhu S, Fisher SG, Carey TE, Bradford CR (2002) Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. Head Neck 24:841–849.  https://doi.org/10.1002/hed.10146 CrossRefGoogle Scholar
  45. 45.
    Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M (1998) Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer. Oncogene 16:2469.  https://doi.org/10.1038/sj.onc.1201776 CrossRefGoogle Scholar
  46. 46.
    Lee LN, Shew JY, Sheu JC, Lee YC, Lee WC, Fang MT, Chang HF, Yu CJ, Yang PC, Luh KT (1994) Exon 8 mutation of p53 gene associated with nodal metastasis in non-small-cell lung cancer. Am J Respir Crit Care Med 150:1667–1671.  https://doi.org/10.1164/ajrccm.150.6.7952630 CrossRefGoogle Scholar
  47. 47.
    Kozomara R, Brankovic-Magic M, Jovic N, Stosic S, Magic Z (2007) Prognostic significance of TP53 mutations in oral squamous cell carcinoma with human papilloma virus infection. Int J Biol Markers 22:252–257.  https://doi.org/10.1177/172460080702200403 CrossRefGoogle Scholar

Copyright information

© Arányi Lajos Foundation 2019

Authors and Affiliations

  • Tipaya Ekalaksananan
    • 1
    • 2
  • Weerayut Wongjampa
    • 1
    • 2
  • Pensiri Phusingha
    • 1
    • 2
  • Jureeporn Chuerduangphui
    • 1
    • 2
  • Patravoot Vatanasapt
    • 2
    • 3
  • Supannee Promthet
    • 2
    • 4
  • Natcha Patarapadungkit
    • 2
    • 5
  • Chamsai Pientong
    • 1
    • 2
    Email author
  1. 1.Department of Microbiology, Faculty of MedicineKhon Kaen UniversityKhon KaenThailand
  2. 2.HPV & EBV and Carcinogenesis Research GroupKhon Kaen UniversityKhon KaenThailand
  3. 3.Department of Otorhinolaryngology, Faculty of MedicineKhon Kaen UniversityKhon KaenThailand
  4. 4.Department of Epidemiology, Faculty of Public HealthKhon Kaen UniversityKhon KaenThailand
  5. 5.Department of Pathology, Faculty of MedicineKhon Kaen UniversityKhon KaenThailand

Personalised recommendations